UnitedHealthcare To Eliminate Out-of-Pocket Costs on Several Prescription Drugs, Including Insulin, for Eligible Members
2022年7月15日 - 10:43PM
ビジネスワイヤ(英語)
- Eligible members will pay $0 out of pocket for preferred
short and long-acting insulins and emergency use drugs that are
critical in acute, life-saving circumstances
- Action is part of ongoing UnitedHealth Group efforts to
improve access and make prescription drugs more affordable for
people
UnitedHealthcare will eliminate out-of-pocket costs in standard
fully insured group plans for certain preferred prescription drugs,
including insulin and several drugs used to treat emergencies such
as severe allergic reactions, hypoglycemia, opioid overdoses, and
acute asthma attacks. This new standard offering will be available
to group fully insured plans potentially as early as January 1,
2023, subject to any required regulatory approval.
Eliminating out-of-pocket expenses for these critical
medications can help reduce the burden of medical costs on
consumers and encourage better medication adherence, reducing the
risk of complications and expensive hospitalizations.
These actions are part of UnitedHealth Group’s ongoing efforts
to ensure people get the drugs they need and to make health care
more affordable. Offering these preferred drugs at $0 cost share
builds on past moves by both UnitedHealthcare and Optum Rx,
including point-of-sale discounts that have delivered millions of
dollars of savings directly to consumers at the pharmacy
counter.
“High prices are a significant barrier to prescription drugs for
many people, so we are using our unique capabilities to deliver
savings for consumers,” said Brian Thompson, chief executive
officer of UnitedHealthcare. “We are doing what we can to shield
people from the prices set by pharmaceutical companies, and hope
all stakeholders also will act to make prescription drugs more
affordable.”
In addition to insulin, four preferred emergency use medications
will be included in the new standard offering and will also have a
$0 cost share:
- Epinephrine – severe allergic reactions
- Glucagon – hypoglycemia
- Naloxone – opioid overdoses
- Albuterol – acute asthma attacks
About UnitedHealthcare
UnitedHealthcare is dedicated to helping people live healthier
lives and making the health system work better for everyone by
simplifying the health care experience, meeting consumer health and
wellness needs, and sustaining trusted relationships with care
providers. In the United States, UnitedHealthcare offers the full
spectrum of health benefit programs for individuals, employers, and
Medicare and Medicaid beneficiaries, and contracts directly with
more than 1.5 million physicians and care professionals, and 7,000
hospitals and other care facilities nationwide. The company also
provides health benefits and delivers care to people through owned
and operated health care facilities in South America.
UnitedHealthcare is one of the businesses of UnitedHealth Group
(NYSE: UNH), a diversified health care company. For more
information, visit UnitedHealthcare at www.uhc.com or follow
@UHC on Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220715005174/en/
Matt Wiggin UnitedHealthcare 860-702-6142
matthew_n_wiggin@uhc.com
UnitedHealth (NYSE:UNH)
過去 株価チャート
から 3 2024 まで 4 2024
UnitedHealth (NYSE:UNH)
過去 株価チャート
から 4 2023 まで 4 2024